Published in Neuropsychopharmacology on October 15, 2013
The Prodrug 4-Chlorokynurenine Causes Ketamine-Like Antidepressant Effects, but Not Side Effects, by NMDA/GlycineB-Site Inhibition. J Pharmacol Exp Ther (2015) 0.89
Oxytocin prevents ethanol actions at δ subunit-containing GABAA receptors and attenuates ethanol-induced motor impairment in rats. Proc Natl Acad Sci U S A (2015) 0.84
Region specific up-regulation of oxytocin receptors in the opioid oprm1 (-/-) mouse model of autism. Front Pediatr (2014) 0.84
Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date. CNS Drugs (2016) 0.82
Oxytocin for the treatment of drug and alcohol use disorders. Behav Pharmacol (2016) 0.77
Differential behavioral and molecular alterations upon protracted abstinence from cocaine versus morphine, nicotine, THC and alcohol. Addict Biol (2016) 0.77
Carbetocin is a Functional Selective Gq Agonist That Does Not Promote Oxytocin Receptor Recycling After Inducing β-Arrestin-Independent Internalisation. J Neuroendocrinol (2016) 0.77
Dissociation of heroin-induced emotional dysfunction from psychomotor activation and physical dependence among inbred mouse strains. Psychopharmacology (Berl) (2014) 0.76
Maternal Weaning Modulates Emotional Behavior and Regulates the Gut-Brain Axis. Sci Rep (2016) 0.76
Emotional Impairment and Persistent Upregulation of mGlu5 Receptor following Morphine Abstinence: Implications of an mGlu5-MOPr Interaction. Int J Neuropsychopharmacol (2016) 0.75
A two-week pilot study of intranasal oxytocin for cocaine-dependent individuals receiving methadone maintenance treatment for opioid use disorder. Addict Res Theory (2016) 0.75
Parvalbumin Interneurons of Central Amygdala Regulate the Negative Affective States and the Expression of Corticotrophin-Releasing Hormone During Morphine Withdrawal. Int J Neuropsychopharmacol (2016) 0.75
Romantic Love vs. Drug Addiction May Inspire a New Treatment for Addiction. Front Psychol (2016) 0.75
Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron (2005) 10.49
The oxytocin receptor system: structure, function, and regulation. Physiol Rev (2001) 6.97
A role for brain stress systems in addiction. Neuron (2008) 4.71
Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry (2007) 4.37
Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol Psychiatry (2007) 3.13
Sex differences in oxytocin and vasopressin: implications for autism spectrum disorders? Behav Brain Res (2006) 2.18
Brain stress systems in the amygdala and addiction. Brain Res (2009) 2.14
A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) (2001) 2.03
Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci (2012) 2.00
The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci (1998) 1.91
A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction. Clin Psychol Rev (2009) 1.80
Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity. J Neurosci (2004) 1.75
Neuropeptides and social behaviour: effects of oxytocin and vasopressin in humans. Prog Brain Res (2008) 1.71
Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system. Psychopharmacology (Berl) (2008) 1.68
Evaluation of the relationship between anxiety during withdrawal and stress-induced reinstatement of cocaine seeking. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.57
Drug addiction: pathways to the disease and pathophysiological perspectives. Eur Neuropsychopharmacol (2006) 1.48
Vasopressin, oxytocin and social behaviour. Curr Opin Neurobiol (2004) 1.46
The neuropeptide oxytocin facilitates pro-social behavior and prevents social avoidance in rats and mice. Neuropsychopharmacology (2011) 1.40
Breaking the loop: oxytocin as a potential treatment for drug addiction. Horm Behav (2011) 1.40
Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav Pharmacol (1995) 1.36
Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin. Psychosom Med (2011) 1.35
Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal. J Endocrinol (2006) 1.34
Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin. Neuropsychopharmacology (2005) 1.33
In vivo regulation of extracellular signal-regulated protein kinase (ERK) and protein kinase B (Akt) phosphorylation by acute and chronic morphine. J Pharmacol Exp Ther (2004) 1.30
From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use? Br J Pharmacol (2008) 1.28
Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats. Psychopharmacology (Berl) (2005) 1.26
Addiction: pulling at the neural threads of social behaviors. Neuron (2011) 1.23
Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Neuropsychopharmacology (2005) 1.23
Depression in methadone maintenance treatment patients: rate and risk factors. J Affect Disord (2006) 1.22
Treatment of depression in patients with opiate dependence. Biol Psychiatry (2004) 1.16
Involvement of noradrenergic neurotransmission in the stress- but not cocaine-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: role for β-2 adrenergic receptors. Neuropsychopharmacology (2010) 1.14
Examining the role of oxytocin in the interoceptive effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') using a drug discrimination paradigm in the rat. Addict Biol (2010) 1.14
Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine. Biol Psychiatry (2010) 1.14
Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice. Naunyn Schmiedebergs Arch Pharmacol (2007) 1.11
The modulatory role of the lateral septum on neuroendocrine and behavioral stress responses. Neuropsychopharmacology (2010) 1.07
Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats. Neuropharmacology (2009) 1.02
Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement. Neuropharmacology (2009) 1.02
The role of oxytocin-dopamine interactions in cocaine-induced locomotor hyperactivity. Neuropharmacology (1990) 1.01
Oxytocin mediates rodent social memory within the lateral septum and the medial amygdala depending on the relevance of the social stimulus: male juvenile versus female adult conspecifics. Psychoneuroendocrinology (2012) 0.97
Mechanisms underlying aggressive and hostile behavior in amphetamine users. Curr Opin Psychiatry (2009) 0.96
Neuroendocrine mechanisms of stress and social interaction: implications for mental disorders. Curr Opin Psychiatry (2007) 0.95
Physiological parameters of morphine dependence in man--tolerance, early abstinence, protracted abstinence. J Psychiatr Res (1969) 0.93
A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm. Addict Biol (2012) 0.93
A general procedure for analysis of proenkephalin B derived opioid peptides. Regul Pept (1985) 0.91
Forced swim test behavior in postpartum rats. Pharmacol Biochem Behav (2010) 0.89
Trivializing dependence. Br J Addict (1990) 0.88
Oxytocin as a potential mediator and modulator of drug addiction. Addict Biol (2011) 0.88
Oxytocin and a C-terminal derivative (Z-prolyl-D-leucine) attenuate tolerance to and dependence on morphine and interact with dopaminergic neurotransmission in the mouse brain. Neuropharmacology (1985) 0.87
Mouse strain differences in locomotor, sensitisation and rewarding effect of heroin; association with alterations in MOP-r activation and dopamine transporter binding. Eur J Neurosci (2010) 0.86
Assessing the antidepressant-like effects of carbetocin, an oxytocin agonist, using a modification of the forced swimming test. Psychopharmacology (Berl) (2010) 0.86
Withdrawal from chronic morphine administration causes prolonged enhancement of immobility in rat forced swimming test. Psychopharmacology (Berl) (2001) 0.86
Chronic methamphetamine treatment induces oxytocin receptor up-regulation in the amygdala and hypothalamus via an adenosine A2A receptor-independent mechanism. Pharmacol Biochem Behav (2013) 0.85
Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation. Eur J Pharmacol (1998) 0.83
Chronic morphine treatment inhibits oxytocin synthesis in rats. Neuroreport (2000) 0.80
Effects of oxytocin and a derivative (Z-prolyl-D-leucine) on morphine tolerance/withdrawal are mediated by the limbic system. Behav Brain Res (1984) 0.79
Endogenous oxytocin inhibits morphine tolerance through limbic forebrain oxytocin receptors. Brain Res (1988) 0.79
Behaviorally active oxytocin fragments simultaneously attenuate heroin self-administration and tolerance in rats. Life Sci (1985) 0.79
Limbic oxytocin and arginine 8-vasopressin in morphine tolerance and dependence. Exp Brain Res (1987) 0.76